Latuda and Ill-defined disorder - a phase IV clinical study of FDA data

Summary:

Ill-defined disorder is reported as a side effect among people who take Latuda (lurasidone hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Tylenol, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Ill-defined disorder when taking Latuda. It is created by eHealthMe based on reports of 20,677 people who have side effects when taking Latuda from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,461 drugs and 1,258 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.

On Jul, 30, 2026

20,677 people reported to have side effects when taking Latuda.
Among them, 24 people (0.12%) have Ill-defined disorder.

Could Latuda cause Ill-defined disorder?

Among these 24 people:

How long have people been on Latuda when they have Ill-defined disorder? *

What is the gender of people who have Ill-defined disorder when taking Latuda? *

female: 61.9 %
male: 38.1 %

What is the age of people who have Ill-defined disorder when taking Latuda? *

What are other drugs people take besides Latuda? *

What are other side effects people have besides Ill-defined disorder? *

Fatigue (feeling of tiredness): 14 people, 58.33%
Chills (felling of cold): 9 people, 37.50%
Nausea (feeling of having an urge to vomit): 8 people, 33.33%
Chest Pain: 7 people, 29.17%
Headache (pain in head): 7 people, 29.17%
Throat Irritation: 7 people, 29.17%
Skin Irritation: 6 people, 25.00%
Cough: 6 people, 25.00%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 25.00%
Heart Attack: 6 people, 25.00%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 25.00%
Psychotic Disorder: 5 people, 20.83%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 16.67%
Weight Decreased: 1 person, 4.17%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 4.17%
Mood Swings (an extreme or rapid change in mood): 1 person, 4.17%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.17%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and have Ill-defined disorder?

- Check whether Ill-defined disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latuda:

Latuda (21,543 reports)

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ill-defined disorder:

Ill-defined disorder (1,461 drugs)

Browse all the conditions that are associated with Ill-defined disorder:

Ill-defined disorder (1,258 conditions)

Related publications that referenced our studies

Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .
Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride (the active ingredients of Latuda) and Latuda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.